Galecto

-$2.39 (-29.87%) Today
+$0.20 (+3.57%) As of 11:15 AM UTC after-hours

Why Robinhood?

You can buy or sell Galecto and other stocks, options, and ETFs commission-free!

About GLTO

Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211.

CEO
Hans Thalsgård Schambye
Employees
28
Headquarters
Boston, Massachusetts
Founded
2011

GLTO Key Statistics

Market Cap
141.72M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.60M
High Today
$7.80
Low Today
$5.53
Open Price
$6.97
Volume
8.89M
52 Week High
$17.99
52 Week Low
$4.50

GLTO Earnings

-$55.25
-$36.83
-$18.42
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure